A detailed history of Weaver Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Weaver Capital Management LLC holds 6,916 shares of ABT stock, worth $795,270. This represents 0.23% of its overall portfolio holdings.

Number of Shares
6,916
Previous 4,822 43.43%
Holding current value
$795,270
Previous $501 Million 57.37%
% of portfolio
0.23%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$100.07 - $118.13 $209,546 - $247,364
2,094 Added 43.43%
6,916 $788 Million
Q2 2024

Aug 02, 2024

BUY
$100.73 - $112.44 $485,720 - $542,185
4,822 New
4,822 $501 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Weaver Capital Management LLC Portfolio

Follow Weaver Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Capital Management LLC with notifications on news.